This site is intended for UK healthcare professionals only
chronic-conditions-logo
This webcast series and supporting materials was developed by the Chronic Conditions faculty in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the agenda, speaker selection, presentations or collateral content, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.

Chronic Conditions Month 2024

Respiratory

Join us for a series of interactive webinars and podcasts to help you optimise care for people with chronic conditions

The agenda

13.00–13:45

Hot topics in the respiratory world – part 1 • New guidance on diagnosis and care for people with asthma and COPD

13:45-14:20

Managing COPD patients: the prevalence and burden of co-morbidities in COPD.

This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.  

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.

14:20 - 15:00

Hot topics in the respiratory world – part 2 • Essential updates on the management of cough and breathlessness

The speakers

Steve Holmes

GP, Shepton Mallet and Clinical Respiratory Lead, NHS England South West and NHS Somerset

Steve has been a GP partner since 1989 and continues working clinically 5 sessions per week. He is a passionate generalist – but has a respiratory specialist interest. Steve has worked nationally and internationally on respiratory issues – and has more than 200 publications on respiratory topics. He has been involved in national and international guidelines and has worked to promote good quality care for people with long term conditions. He works on educational issues in primary and secondary care – and has regular involvement with Asthma and Lung UK as well as more local patient groups in encouraging change in practice.

He has worked in service development since fundholding in the 1990s through many changes and remains passionate to make a difference.

Steve enjoys music, running, watching rugby and time spent with his wife and two daughters.

Peter Bagshaw

Clinical Lead in Dementia and Mental Health, South Glos CCG, and Director of the South West Clinical Network for Dementia​

Peter Bagshaw has been a GP in for over 30 years, and is currently a partner at Minehead Medical Centre.

He is currently the Mental Health and Dementia Clinical Lead for Somerset CCG, Director of the South West Dementia Clinical Network for Dementia, and Improving Access to Psychological Therapies (IAPT) Clinical Network Lead. He is a member of the National Improvement and Assessment Framework board, Chair of the South West IAPT Expert Reference Group, and Editor for the Dementia and Mental Health section of the online magazine Chronic Conditions.

His outside interests include painting, quantum mechanics and karate. He has written a book on the nature of reality, and is co-author of the recently published Older People’s Mental Health Primer.

Dr Claribel Simmons

Consultant Respiratory Physician Forth Valley Royal Hospital Larbert, Scotland

Dr Claribel Simmons is a Consultant Respiratory Physician based at Forth Valley Royal Hospital, Larbert, Scotland. She has subspecialist interests in lung cancer and integrated care. She graduated from the University of Edinburgh in 2004. She completed her specialty training in Respiratory Medicine in Newcastle. She previously worked as a GP for NHS GGC and NHS Lanarkshire.

In 2018, she was awarded her MD in Prognostication in Advanced Cancer from the University of Edinburgh. She is Deputy Director of Medical Education at the Royal College of Physicians and Surgeons of Glasgow.

Therapy webcast sponsor

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its medicines are used by millions of patients worldwide.

With a proud 100-year heritage in advancing UK science, today AstraZeneca is the UK’s leading biopharmaceutical company. AstraZeneca is based in six different locations across the UK, with its global headquarters in Cambridge. In the UK, around 8,600 employees work in research and development, manufacturing, supply, sales and marketing. We supply around 35 different medicines to the NHS.

For healthcare professionals only

Are you a healthcare professional?

The information is intended for healthcare professionals only.
Please confirm below.